跳至主要内容
临床试验/NCT02771327
NCT02771327已完成4 期

Phase 4, Randomized, Controlled Trial on the Efficacy as Prophylaxis of Postoperative Respiratory Complications and Safety of Continuous Positive Airways Pressure (CPAP) Applied Throughout Boussignac Mask During the Immediate Postoperative Period of Patients Undergoing Lung Resection

Hospital General Universitario Gregorio Marañon4 个研究点 分布在 1 个国家目标入组 258 人开始时间: 2014年2月1日最近更新:
适应症
干预措施

试验速览

阶段
4 期
状态
已完成
发起方
入组人数
258
试验地点
4
主要终点
Frequency of atelectasis- Pneumonia, and other postoperative complications,

研究概览

简要总结

Evaluation of efficacy and safety from 6hours of 7 cmH2O CPAP after weaning in patients undergoing lung resection, on the prevention of atelectasis / pneumonia and gas exchange improve.

详细描述

Multicenter randomized clinical trial. 460 patients randomly assigned to treatment and control groups will be studied. The main variables are the frequency of atelectasis or pneumonia, defined by clinical and radiological criteria, the FiO2/PaO2 ratio, 7 and 24 h after weaning, and hospital stay.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Prevention
盲法
None

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者
否

入选标准

  • •Undergoing thoracic surgery including resection of lung parenchyma.
  • •To have given signed consent to enter in the study.

排除标准

  • •Weaning in the first 4h after the intervention end.
  • •Suspected bronchopleural fistula at the admission to the surgical ICU.
  • •Patients with facial problems or a history of intolerance to CPAP masks.
  • •Having significant bullous emphysema defined as the presence of more than 5 contiguous bullae <2cm or the existence of a pulmonary bulla> 2 cm or dystrophy bullosa, not in the area to dry and having had a previous pneumothorax.
  • •Known Obstructive Apnea Hypopnea syndrome known or some form of noninvasive ventilation prescribed.
  • •Immunocompromised patients, or having used an immunosuppressor drug at least one month prior to surgery with potential (except corticosteroids administered by inhalation)

研究组 & 干预措施

CPAP plus gas

Experimental

Treatment with Boussingnac valve CPAP during 6 hour, starting immediately after weaning

干预措施: CPAP plus Gas (Device)

Usual treatment(ventimask plus gas)

Active Comparator

ventimask

干预措施: ventimask plus gas (Device)

结局指标

主要结局

Frequency of atelectasis- Pneumonia, and other postoperative complications,

时间窗: 1 week after the surgical intervention

次要结局

  • Gas exchange ( Pa/FiO2)(1 week after the surgical intervention)
  • Hospital stay comparison between arms(from the surgical intervention date to hospital discharge date up to 1month)

研究者

发起方
Hospital General Universitario Gregorio Marañon
申办方类型
Other
责任方
Sponsor

研究点 (4)

Loading locations...

相似试验